পিত্ত নলীৰ কেন্সাৰ
Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
ক’ত যাব
ভাৰতৰ 3 খন হস্পিতালত এই trial-ৰ বাবে ৰোগী ভৰ্তি কৰা হৈছে।
ৰেজিষ্ট্ৰীৰ সাৰাংশ (কাৰিকৰী)
This is a randomized, open-label, two-arm, Phase III clinical trial evaluating the efficacy and safety of trastuzumab plus chemotherapy versus chemotherapy alone as first-line treatment in patients with HER2-positive advanced or metastatic biliary tract cancers (BTC). HER2-positive BTCs represent a molecular subset of these rare cancers, associated with poor prognosis and limited treatment options. Eligible patients with histologically confirmed HER2-positive (IHC 3+ or IHC 2+ with FISH amplification) unresectable or metastatic biliary tract adenocarcinoma-including gallbladder cancer, intrah…
স্পন্সৰ: টাটা মেমৰিয়েল চেণ্টাৰ
ClinicalTrials.gov-ত NCT07062263
ৰেজিস্ট্ৰিত অন্তিম আপডেট 14 Jul 2025 · আমাৰ দ্বাৰা 20 Oct 2026-ত পঢ়া হৈছে